| Field | Row 1 |
|---|---|
| adsh | 0001628280-25-025077 |
| cik | 1672688 |
| name | ABSCI CORP |
| sic | 8731 |
| countryba | US |
| stprba | WA |
| cityba | VANCOUVER |
| zipba | 98683 |
| bas1 | 18105 SE MILL PLAIN BLVD |
| bas2 | |
| baph | (360) 949-1041 |
| countryma | US |
| stprma | WA |
| cityma | VANCOUVER |
| zipma | 98683 |
| mas1 | 18105 SE MILL PLAIN BLVD |
| mas2 | |
| countryinc | |
| stprinc | |
| ein | 853383487 |
| former | ABSCI CORP |
| changed | 20201026 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-13 16:09:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | absi-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001628280-25-025077 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3544000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3544000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20240331 | Earnings Per Share Diluted | -0.2200 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Finance Lease Principal Payments | 401000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Increase Decrease In Other Accounts Payable And Accrued Liabilities | -3905000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Increase Decrease In Other Noncurrent Assets | -4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Liabilities And Stockholders Equity | 213608000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Operating Expenses | 28908000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Operating Income Loss | -23498000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Operating Lease Liability Noncurrent | 4429000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Other Assets Noncurrent | 705000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -48000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-025077 | 20250331 | Other Nonoperating Income Expense | 1458000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Prepaid Expense And Other Assets Current | 5459000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Restricted Cash | 15947000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Accounts Payable Current | 3529000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 631000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Assets Current | 133831000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Other Liabilities Noncurrent | 133000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 192000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Cash And Cash Equivalents At Carrying Value | 41213000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 89667000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 64125000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001628280-25-025077 | 20250331 | Comprehensive Income Net Of Tax | -26323000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -26350000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Income Tax Expense Benefit | 12000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Increase Decrease In Contract With Customer Liability | -898000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Increase Decrease In Contract With Customer Liability | -20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Increase Decrease In Other Accounts Payable And Accrued Liabilities | -3407000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Increase Decrease Operating Lease Right Of Use Assets And Liabilities | -126000.0000 | USD | 1 | 0001628280-25-025077 | |||
| 0001628280-25-025077 | 20241231 | Intangible Assets Net Excluding Goodwill | 44883000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Liabilities Current | 28656000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Net Cash Provided By Used In Financing Activities | 42794000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Operating Lease Liability Noncurrent | 4003000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -54000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -47000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-025077 | 20240331 | Other Operating Activities Cash Flow Statement | -56000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Other Operating Activities Cash Flow Statement | 7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Restricted Cash | 16076000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period | 1195012.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20240331 | Stockholders Equity | 11000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20250331 | Stockholders Equity | 13000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20250331 | Stock Issued During Period Value New Issues | 39158000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20250331 | Restricted Cash Noncurrent | 1054000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Stockholders Equity | 668698000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20241231 | Stockholders Equity | 179133000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 99393333.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Capital Expenditures Incurred But Not Yet Paid | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001628280-25-025077 | 20241231 | Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Current | 71212000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Depreciation Depletion And Amortization | 3416000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Depreciation Depletion And Amortization | 3416000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Segment One; | ||
| 0001628280-25-025077 | 20250331 | Depreciation Depletion And Amortization | 3072000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Increase Decrease In Accounts Payable | 1226000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Increase Decrease In Other Noncurrent Assets | -1000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Intangible Assets Net Excluding Goodwill | 44041000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Interest Expense Nonoperating | 79000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Net Cash Provided By Used In Investing Activities | -15044000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Operating Expenses | 24396000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 77000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-025077 | 20250331 | Payments Of Stock Issuance Costs | 744000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Proceeds From Sale And Maturity Of Held To Maturity Securities | 25000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Proceeds From Sale Of Property Plant And Equipment | 113000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Research And Development Expense | 4006000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Segment One; Product Or Service= Drug Creation And Platform; | ||
| 0001628280-25-025077 | 20231231 | Stockholders Equity | -37000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-025077 | 20241231 | Stockholders Equity | 688726000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20250331 | Stockholders Equity | 734711000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20250331 | Stock Issued During Period Value New Issues | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20241231 | Accounts Receivable Net Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Accounts Receivable Net Current | 1384000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Accrued Liabilities Current | 6842000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Additional Paid In Capital Common Stock | 734711000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Assets Current | 155978000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Common Stock Shares Outstanding | 112998922.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20250331 | Common Stock Value | 13000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Current | 86988000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Depreciation Depletion And Amortization | 3072000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Segment One; | ||
| 0001628280-25-025077 | 20250331 | Earnings Per Share Diluted | -0.2100 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -520000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Liabilities Current | 27281000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Net Cash Provided By Used In Operating Activities | -21839000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Net Income Loss | -26346000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-025077 | 20240331 | Nonoperating Income Expense | 1535000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Other Liabilities Noncurrent | 1685000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Payments To Acquire Available For Sale Securities Debt | 97330000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Payments To Acquire Property Plant And Equipment | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 27027000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Repayments Of Long Term Debt | 872000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Repayments Of Long Term Debt | 762000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Research And Development Expense | 27000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Segment One; Product Or Service= External Pre Clinical And Clinical Development; | ||
| 0001628280-25-025077 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 1179000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20231231 | Stockholders Equity | 176176000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Stockholders Equity | -132000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-025077 | 20241231 | Stockholders Equity | -509601000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-025077 | 20250331 | Stockholders Equity | 19000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-025077 | 20250331 | Stock Issued During Period Shares New Issues | 10983477.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20240331 | Stock Issued During Period Value New Issues | 80825000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 124461439.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 699000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Additional Paid In Capital Common Stock | 688726000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Assets | 232447000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -13360000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20231231 | Common Stock Shares Outstanding | 93087675.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20241231 | Common Stock Value | 12000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Earnings Per Share Basic | -0.2100 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Finance Lease Liability Current | 78000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Finance Lease Principal Payments | 47000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Increase Decrease In Accounts Payable | 150000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -924000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Other Nonoperating Income Expense | 1711000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Interest Expense Nonoperating | 176000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Liabilities | 34475000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Net Cash Provided By Used In Investing Activities | -76681000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Nonoperating Income Expense | 1379000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Notes Payable Current | 2733000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Notes Payable Current | 2544000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Operating Lease Liability Current | 1608000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Operating Lease Right Of Use Asset | 3716000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -48000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250131 | Payments Of Stock Issuance Costs | 2500000.0000 | USD | 0 | us-gaap/2024 | Counterparty Name= Advanced Micro Devices Inc; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001628280-25-025077 | 20250331 | Payments To Acquire Available For Sale Securities Debt | 40132000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Proceeds From Issuance Of Common Stock | 41689000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Proceeds From Sale Of Property Plant And Equipment | 149000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Retained Earnings Accumulated Deficit | -535947000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Share Based Compensation | 3590000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Net Of Forfeitures | 1630000.0000 | USD | 1 | 0001628280-25-025077 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20231231 | Stockholders Equity | 582699000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20231231 | Stockholders Equity | -406495000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-025077 | 20250331 | Stockholders Equity | 198796000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Stockholders Equity | -535947000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-025077 | 20250331 | Accounts Payable Current | 4947000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Accrued Liabilities Current | 4256000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 19000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4913000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4913000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20241231 | Business Combination Contingent Consideration Liability Current | 12750000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Cash And Cash Equivalents At Carrying Value | 46995000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 76307000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Comprehensive Income Net Of Tax | -22070000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Contract With Customer Liability Current | 1096000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -21963000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Increase Decrease In Accounts Receivable | -2147000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Long Term Notes Payable | 1257000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Net Cash Provided By Used In Financing Activities | 81184000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Net Cash Provided By Used In Operating Activities | -17863000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Operating Expenses | 24396000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Segment One; | ||
| 0001628280-25-025077 | 20250331 | Operating Income Loss | -27729000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Operating Lease Right Of Use Asset | 3968000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -47000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 77000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Payments To Acquire Property Plant And Equipment | 25000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Proceeds From Issuance Of Common Stock | 80827000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Proceeds From Sale And Maturity Of Held To Maturity Securities | 20500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Retained Earnings Accumulated Deficit | -509601000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Net Of Forfeitures | 1630000.0000 | USD | 1 | 0001628280-25-025077 | |||
| 0001628280-25-025077 | 20250331 | Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Net Of Forfeitures | 1914000.0000 | USD | 1 | 0001628280-25-025077 | |||
| 0001628280-25-025077 | 20250331 | Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Net Of Forfeitures | 1914000.0000 | USD | 1 | 0001628280-25-025077 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-025077 | 20231231 | Stockholders Equity | 9000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20240331 | Stock Issued During Period Shares New Issues | 19205000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20240331 | Stock Issued During Period Value New Issues | 2000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20250331 | Stock Issued During Period Value New Issues | 39159000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 99393333.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 124461439.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Contract With Customer Liability Current | 1116000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Earnings Per Share Basic | -0.2200 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Finance Lease Liability Current | 32000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Income Tax Expense Benefit | -4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Increase Decrease In Accounts Receivable | 1384000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Liabilities | 33651000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Net Income Loss | -21975000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Net Income Loss | -26346000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Operating Expenses | 28908000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Segment One; | ||
| 0001628280-25-025077 | 20250331 | Operating Lease Liability Current | 1656000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -54000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-025077 | 20250331 | Prepaid Expense And Other Assets Current | 4535000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 29167000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Research And Development Expense | 12236000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Research And Development Expense | 3629000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Segment One; Product Or Service= Drug Creation And Platform; | ||
| 0001628280-25-025077 | 20250331 | Research And Development Expense | 16364000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Research And Development Expense | 2684000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Segment One; Product Or Service= External Pre Clinical And Clinical Development; | ||
| 0001628280-25-025077 | 20250331 | Share Based Compensation | 4913000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period | 706247.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20240331 | Stockholders Equity | 240107000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Stockholders Equity | -4000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-025077 | 20240331 | Stock Issued During Period Value New Issues | 80827000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -4000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Assets | 213608000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Business Combination Contingent Consideration Liability Current | 12750000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 58214000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 5911000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Common Stock Shares Outstanding | 115362265.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20250331 | Common Stock Shares Outstanding | 127540754.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-025077 | 20240331 | Increase Decrease Operating Lease Right Of Use Assets And Liabilities | -225000.0000 | USD | 1 | 0001628280-25-025077 | |||
| 0001628280-25-025077 | 20250331 | Liabilities And Stockholders Equity | 232447000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Long Term Notes Payable | 682000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Net Income Loss | -21975000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-025077 | 20250331 | Other Assets Noncurrent | 631000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Payments Of Stock Issuance Costs | 411000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Proceeds From Stock Plans | 1630000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Proceeds From Stock Plans | 1914000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20241231 | Restricted Cash Noncurrent | 1054000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 898000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Selling General And Administrative Expense | 8744000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20250331 | Selling General And Administrative Expense | 9472000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-025077 | 20240331 | Stockholders Equity | -428470000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-025077 | 20241231 | Stockholders Equity | 12000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Net Of Forfeitures | 0001628280-25-025077 | 1 | 0 | monetary | D | C | Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Net Of Forfeitures | Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Net Of Forfeitures |
| Increase Decrease Operating Lease Right Of Use Assets And Liabilities | 0001628280-25-025077 | 1 | 0 | monetary | D | D | Increase (Decrease) Operating Lease Right-Of-Use Assets And Liabilities | Increase (Decrease) Operating Lease Right-Of-Use Assets And Liabilities |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Sale And Maturity Of Held To Maturity Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Held-to-Maturity Securities | Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Long Term Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent. |
| Other Operating Activities Cash Flow Statement | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Operating Activities, Cash Flow Statement | Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities). |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Business Combination Contingent Consideration Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Business Combination, Contingent Consideration, Liability, Current | Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Finance Lease Principal Payments | us-gaap/2024 | 0 | 0 | monetary | D | C | Finance Lease, Principal Payments | Amount of cash outflow for principal payment on finance lease. |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Payments To Acquire Available For Sale Securities Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Debt Securities, Available-for-Sale | Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Repayments Of Long Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Long-Term Debt | The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer. |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Restricted Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash | Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Proceeds From Stock Plans | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Plans | The cash inflow associated with the amount received from the stock plan during the period. |
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization | Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset. |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss, Current | Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Contract With Customer Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Revenue From Contract With Customer Including Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Including Assessed Tax | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. |
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures | Net number of share options (or share units) granted during the period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Finance Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from finance lease, classified as current. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001628280-25-025077 | 6 | 13 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001628280-25-025077 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001628280-25-025077 | 2 | 4 | BS | 0 | H | Restricted Cash | us-gaap/2024 | Restricted cash | 0 |
| 0001628280-25-025077 | 2 | 5 | BS | 0 | H | Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Current | us-gaap/2024 | Short-term investments | 0 |
| 0001628280-25-025077 | 2 | 6 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001628280-25-025077 | 2 | 7 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001628280-25-025077 | 2 | 8 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001628280-25-025077 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0001628280-25-025077 | 2 | 10 | BS | 0 | H | Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | us-gaap/2024 | Property and equipment, net | 0 |
| 0001628280-25-025077 | 2 | 11 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangibles, net | 0 |
| 0001628280-25-025077 | 2 | 12 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash, long-term | 0 |
| 0001628280-25-025077 | 2 | 13 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other long-term assets | 0 |
| 0001628280-25-025077 | 2 | 14 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001628280-25-025077 | 2 | 17 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001628280-25-025077 | 2 | 18 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001628280-25-025077 | 2 | 19 | BS | 0 | H | Business Combination Contingent Consideration Liability Current | us-gaap/2024 | Contingent consideration | 0 |
| 0001628280-25-025077 | 2 | 20 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Long-term debt | 0 |
| 0001628280-25-025077 | 2 | 21 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease obligations | 0 |
| 0001628280-25-025077 | 2 | 22 | BS | 0 | H | Finance Lease Liability Current | us-gaap/2024 | Financing lease obligations | 0 |
| 0001628280-25-025077 | 2 | 23 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2024 | Deferred revenue | 0 |
| 0001628280-25-025077 | 2 | 24 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001628280-25-025077 | 2 | 25 | BS | 0 | H | Long Term Notes Payable | us-gaap/2024 | Long-term debt, net of current portion | 0 |
| 0001628280-25-025077 | 2 | 26 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease obligations, net of current portion | 0 |
| 0001628280-25-025077 | 2 | 27 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other long-term liabilities | 0 |
| 0001628280-25-025077 | 2 | 28 | BS | 0 | H | Liabilities | us-gaap/2024 | TOTAL LIABILITIES | 0 |
| 0001628280-25-025077 | 2 | 29 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments (See Note 6) | 0 |
| 0001628280-25-025077 | 2 | 31 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock | 0 |
| 0001628280-25-025077 | 2 | 32 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock | 0 |
| 0001628280-25-025077 | 2 | 33 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001628280-25-025077 | 2 | 34 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001628280-25-025077 | 2 | 35 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income (loss) | 0 |
| 0001628280-25-025077 | 2 | 36 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL STOCKHOLDERS' EQUITY | 0 |
| 0001628280-25-025077 | 2 | 37 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | 0 |
| 0001628280-25-025077 | 3 | 2 | IS | 0 | H | Revenue From Contract With Customer Including Assessed Tax | us-gaap/2024 | Partner program revenue | 0 |
| 0001628280-25-025077 | 3 | 4 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001628280-25-025077 | 3 | 5 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0001628280-25-025077 | 3 | 6 | IS | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001628280-25-025077 | 3 | 7 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001628280-25-025077 | 3 | 8 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0001628280-25-025077 | 3 | 10 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0001628280-25-025077 | 3 | 11 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income, net | 0 |
| 0001628280-25-025077 | 3 | 12 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income, net | 0 |
| 0001628280-25-025077 | 3 | 13 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001628280-25-025077 | 3 | 14 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax benefit (expense) | 1 |
| 0001628280-25-025077 | 3 | 15 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-025077 | 3 | 16 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share: basic (in usd per share) | 0 |
| 0001628280-25-025077 | 3 | 17 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share: diluted (in usd per share) | 0 |
| 0001628280-25-025077 | 3 | 18 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average common shares outstanding: basic (in shares) | 0 |
| 0001628280-25-025077 | 3 | 19 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average common shares outstanding: diluted (in shares) | 0 |
| 0001628280-25-025077 | 3 | 21 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-025077 | 3 | 22 | IS | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Foreign currency translation adjustments | 0 |
| 0001628280-25-025077 | 3 | 23 | IS | 0 | H | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Unrealized loss on investments | 0 |
| 0001628280-25-025077 | 3 | 24 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0001628280-25-025077 | 4 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0001628280-25-025077 | 4 | 11 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0001628280-25-025077 | 4 | 12 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common shares, net of issuance costs | 0 |
| 0001628280-25-025077 | 4 | 13 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common shares, net of issuance costs (in shares) | 0 |
| 0001628280-25-025077 | 4 | 14 | EQ | 0 | H | Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Net Of Forfeitures | 0001628280-25-025077 | Issuance of shares under stock plans, net of shares withheld for tax payments | 0 |
| 0001628280-25-025077 | 4 | 15 | EQ | 0 | H | Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period | us-gaap/2024 | Issuance of shares under stock plans, net of shares withheld for tax payments (in shares) | 0 |
| 0001628280-25-025077 | 4 | 16 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0001628280-25-025077 | 4 | 17 | EQ | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Foreign currency translation adjustments | 0 |
| 0001628280-25-025077 | 4 | 18 | EQ | 0 | H | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Unrealized loss on investments | 0 |
| 0001628280-25-025077 | 4 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-025077 | 4 | 20 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0001628280-25-025077 | 4 | 21 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0001628280-25-025077 | 5 | 1 | EQ | 1 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Stock issuance costs | 0 |
| 0001628280-25-025077 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-025077 | 6 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001628280-25-025077 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001628280-25-025077 | 6 | 6 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Accretion of discount on short-term investments | 1 |
| 0001628280-25-025077 | 6 | 7 | CF | 0 | H | Other Operating Activities Cash Flow Statement | us-gaap/2024 | Other | 0 |
| 0001628280-25-025077 | 6 | 9 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable, net | 1 |
| 0001628280-25-025077 | 6 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001628280-25-025077 | 6 | 11 | CF | 0 | H | Increase Decrease Operating Lease Right Of Use Assets And Liabilities | 0001628280-25-025077 | Operating lease right-of-use assets and liabilities | 0 |
| 0001628280-25-025077 | 6 | 12 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Other long-term assets | 1 |
| 0001628280-25-025077 | 6 | 14 | CF | 0 | H | Increase Decrease In Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0001628280-25-025077 | 6 | 15 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2024 | Deferred revenue | 0 |
| 0001628280-25-025077 | 6 | 16 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001628280-25-025077 | 6 | 18 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0001628280-25-025077 | 6 | 19 | CF | 0 | H | Payments To Acquire Available For Sale Securities Debt | us-gaap/2024 | Investment in short-term investments | 1 |
| 0001628280-25-025077 | 6 | 20 | CF | 0 | H | Proceeds From Sale And Maturity Of Held To Maturity Securities | us-gaap/2024 | Proceeds from maturities of short-term investments | 0 |
| 0001628280-25-025077 | 6 | 21 | CF | 0 | H | Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | Proceeds from sales of property and equipment | 0 |
| 0001628280-25-025077 | 6 | 22 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001628280-25-025077 | 6 | 24 | CF | 0 | H | Repayments Of Long Term Debt | us-gaap/2024 | Principal payments on long-term debt | 1 |
| 0001628280-25-025077 | 6 | 25 | CF | 0 | H | Finance Lease Principal Payments | us-gaap/2024 | Principal payments on finance lease obligations | 1 |
| 0001628280-25-025077 | 6 | 26 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of common stock, net | 0 |
| 0001628280-25-025077 | 6 | 27 | CF | 0 | H | Proceeds From Stock Plans | us-gaap/2024 | Proceeds from issuance of common stock through employee equity plans, net | 0 |
| 0001628280-25-025077 | 6 | 28 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001628280-25-025077 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash, cash equivalents, and restricted cash | 0 |
| 0001628280-25-025077 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash - Beginning of period | 0 |
| 0001628280-25-025077 | 6 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents, and restricted cash - End of period | 0 |
| 0001628280-25-025077 | 6 | 33 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | Property and equipment purchases included in accounts payable | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |